The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Learn ways to automate your savings for effortless financial growth. Simplify your saving habits and watch your funds grow.
17,672 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
As gasoline prices stay stubbornly high, Americans are cutting driving and postponing trips to protect household budg...
SpaceX’s long-anticipated S-1 lays out revenue and losses, yet key subscription and launch-cost details are absent, c...
As inflation remains stubborn, Bank of America nudges its rate outlook higher, forecasting three quarter-point Fed hi...
Gen Z accounted for a record 20% of rate locks in Q2, marking a major shift in the homebuying landscape as affordabil...
Amazon’s chip initiative is quietly redefining cloud economics. This article breaks down the numbers, the tech stack,...
A California elementary student is taking college coursework while still in elementary school, prompting a closer loo...
A massive new funding request for Iran-related operations has financial markets and households weighing the longer-te...
A top economist says wage gains aren’t keeping up with inflation, leaving Americans literally getting squeezed as hou...
The in-flight internet race is heating up. As Starlink expands across fleets, American Airlines could gain a meaningf...
A new Morgan Stanley Research report argues that housing affordability unlikely return to pre-2022 levels as rates st...
NVIDIA faces growing pressure from customers exploiting cheaper compute options and in-house silicon, threatening its...